Steven M. Fruchtman
2022
In 2022, Steven M. Fruchtman earned a total compensation of $1.3M as President and Chief Executive Officer at Onconova Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Bonus | $251,769 |
|---|---|
| Option Awards | $302,516 |
| Salary | $630,000 |
| Stock Awards | $116,407 |
| Other | $26,090 |
| Total | $1,326,782 |
Fruchtman received $630K in salary, accounting for 47% of the total pay in 2022.
Fruchtman also received $251.8K in bonus, $302.5K in option awards, $116.4K in stock awards and $26.1K in other compensation.
Rankings
In 2022, Steven M. Fruchtman's compensation ranked 2,484th out of 5,760 executives tracked by ExecPay. In other words, Fruchtman earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,484 out of 5,760 | 57th |
Division Manufacturing | 1,364 out of 3,136 | 57th |
Major group Chemicals And Allied Products | 616 out of 1,422 | 57th |
Industry group Drugs | 570 out of 1,323 | 57th |
Industry Pharmaceutical Preparations | 408 out of 969 | 58th |
Source: SEC filing on June 7, 2023.
Fruchtman's colleagues
We found two more compensation records of executives who worked with Steven M. Fruchtman at Onconova Therapeutics in 2022.
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019